Skip to main content

Table 1 Application of the BLDM model and ultrasonography in identifying MTN and BTN samples

From: Blood leukocytes as a non-invasive diagnostic tool for thyroid nodules: a prospective cohort study

(%)

Validation cohort

Independent test cohort

 

 > 10 mm

 ≤ 10 mm

 

 > 10 mm

 ≤ 10 mm

BLDM

US

BLDM

US

BLDM

US

BLDM

US

BLDM

US

BLDM

US

Sensitivity

83.33

97.62

66.67

83.33

86.11

100

82.86

100.00

75.00

100.00

83.87

100.00

Specificity

90.91

43.64

90.00

57.50

93.33

6.67

88.68

47.17

85.71

67.86

92.00

24.00

Accuracy

87.63

67.01

86.96

60.87

88.24

72.55

86.36

68.18

84.38

71.88

87.50

66.07

PPV

87.50

56.94

50.00

22.73

96.88

72.00

82.86

55.56

42.86

30.77

92.86

62.00

NPV

87.72

96.00

94.74

95.83

73.68

100.00

88.68

100.00

96.00

100.00

82.14

100.00

AUC

0.86

0.85

0.87

0.87

0.86

0.65

0.86

0.82

0.87

0.98

0.86

0.68

  1. MTN Malignant thyroid nodule, BTN Benign thyroid nodule, US Ultrasonography, PPV Positive predictive value, NPV Negative predictive value, AUC Area under the curve